Royalty Pharma Plc(RPRX)— 技术面状态
数据截至2026-10-14 — 每个交易日晚间对全部覆盖范围重新计算。Closelook研究日记,不构成投资建议。
Trades -0.2% vs the 50-day and +14.2% vs the 200-day average, 8.4% below the 52-week high and +68.7% off the 52-week low. Computed from daily closes.
均线状态
- 相对20日均线+2.2%
- 相对50日均线-0.2%
- 相对200日均线+14.2%
- 52周区间低于52周高点8.4% · 高于52周低点68.7%
- 连续走势连续1个交易日上涨
- 50日均线交叉股价向下穿越50日均线(24个交易日前)
- 随机指标%K 98 · %D 50.9(金叉)
FAQ · from the current data · as of 2026-10-14
Quick answers
RPRX当前的Closelook信号是什么?
Pullback inside an uptrend stack — Trades -0.2% vs the 50-day and +14.2% vs the 200-day average, 8.4% below the 52-week high and +68.7% off the 52-week low. Computed from daily closes.(截至2026-10-14;信号看板每个交易日晚间对全部覆盖范围重新计算。研究日记读数,不构成投资建议。)
RPRX目前是否位于50日和200日均线上方?
截至2026-10-14,Royalty Pharma Plc位于50日均线下方(-0.2%),200日均线上方(+14.2%);距20日均线+2.2%。
RPRX距52周高点有多远?
截至2026-10-14,低于52周高点8.4%,高于52周低点68.7%。
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ARGX argenx NV ADRindustry
- KRYS Krystal Biotech Incindustry
- UCB.BR UCB SAindustry
- PTGX Protagonist Therapeutics Incindustry
- MRNA Moderna Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- CAI Caris Life Sciences, Inc. Common Stockindustry
- EXEL Exelixis Incindustry
- RXRX Recursion Pharmaceuticals Incindustry
- TWST Twist Bioscience Corpindustry
- TECH Bio-Techne Corpindustry
- ONC BeiGene, Ltd.industry
- REGN Regeneron Pharmaceuticals Incindustry
- RVMD Revolution Medicines Incindustry
- BION.SW BB Biotech AGindustry
- ROIV Roivant Sciences Ltdindustry
- INCY Incyte Corporationindustry